Prosecution Insights
Prosecution Insights
Technology areas: Computing & Software • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Ace Vision Group Inc. currently manages 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 3 distinct examiners and 2 distinct art units. This distribution suggests a varied examination environment for the portfolio. The use of multiple examiners ensures that each application receives attention from a different official, which can provide diverse perspectives on the claimed inventions.
The busiest examiner for this portfolio is CHRISTIANSON, SKYLAR LINDSEY, who is responsible for 1 pending office action. This specific examiner represents a portion of the total workload currently being navigated by the company. The presence of 2 distinct art units indicates that the medical and mechanical aspects of the filings are being reviewed by different specialized groups. Because there are 3 distinct examiners involved, the company must manage interactions across multiple technical divisions to ensure consistent prosecution results.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHRISTIANSON, SKYLAR LINDSEY | 1 | 59.6% | +27.7% |
| LUKJAN, SEBASTIAN X | 1 | 76.3% | +40.3% |
| COOK, BRIAN S | 1 | 62.2% | +29.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19041801 | SYSTEMS AND METHODS FOR OCULAR LASER SURGERY AND THERAPEUTIC TREATMENTS | CHRISTIANSON, SKYLAR LINDSEY | — |
| 19028482 | SYSTEM AND METHOD FOR TREATING CONNECTIVE TISSUE | LUKJAN, SEBASTIAN X | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571372 | 3-DIMENSIONAL MODEL CREATION USING WHOLE EYE FINITE ELEMENT MODELING OF HUMAN OCULAR STRUCTURES | COOK, BRIAN S | 34d |
| 19041801 | SYSTEMS AND METHODS FOR OCULAR LASER SURGERY AND THERAPEUTIC TREATMENTS | CHRISTIANSON, SKYLAR LINDSEY | — |
| 19028482 | SYSTEM AND METHOD FOR TREATING CONNECTIVE TISSUE | LUKJAN, SEBASTIAN X | — |
| Art Unit | Apps |
|---|---|
| 3792 | 2 |
| 2187 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19041801 | SYSTEMS AND METHODS FOR OCULAR LASER SURGERY AND THERAPEUTIC TREATMENTS | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §103§112 | Final Rejection | — | Pending | Jan 30, 2025 |
| 19028482 | SYSTEM AND METHOD FOR TREATING CONNECTIVE TISSUE | LUKJAN, SEBASTIAN X | 3792 | §103§112Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 17571372 | 3-DIMENSIONAL MODEL CREATION USING WHOLE EYE FINITE ELEMENT MODELING OF HUMAN OCULAR STRUCTURES | COOK, BRIAN S | 2187 | §103 | Non-Final OA | 34d | Pending | Jan 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial